Medtronic (MDT) Long-Term Investments (2014 - 2018)

Medtronic has disclosed Long-Term Investments across 5 years of filings, most recently posting $515.0 million for Q2 2018.

• Long-Term Investments for Q2 2018 came in at $515.0 million, down 94.21% year-over-year; the trailing twelve-month figure through Apr 2018 was $515.0 million (down 94.21% YoY), and the FY2018 annual result was $515.0 million, down 94.21% from the prior year.
• Long-Term Investments came in at $515.0 million for Q2 2018 at Medtronic, down from $8.3 billion in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $15.2 billion in Q3 2015 to a low of $515.0 million in Q2 2018.
• The 5-year median for Long-Term Investments is $9.4 billion (2016), against an average of $10.3 billion.
• Across the five-year window, Long-Term Investments grew 14.08% in 2015 and slumped 94.21% in 2018, its largest moves.
• Medtronic's Long-Term Investments stood at $13.0 billion in 2014, then gained by 15.85% to $15.1 billion in 2015, then sank by 43.98% to $8.4 billion in 2016, then fell by 2.29% to $8.2 billion in 2017, then plunged by 93.75% to $515.0 million in 2018.
• The last three Long-Term Investments figures came in at $515.0 million (Q2 2018), $8.3 billion (Q1 2018), and $8.2 billion (Q4 2017), per Business Quant data.